Skip to content

Monthly Archives: January 2013

Quizartinib: Surprising, Unprecedented Activity in Relapsed AML


ATLANTA, Georgia — The investigational agent quizartinib (Astellas/Ambit) has shown unprecedented activity in patients with relapsed and refractory acute myeloid leukemia (AML) in a phase 2 clinical trial. On the basis of these results, larger phase 3 clinical trials with the drug are being planned, according to Astellas/Ambit. Patients with AML can develop many different […]

The Management of Waldenstrom Macroglobulinemia


Definition Waldenstrom macroglobulinemia (WM) is a distinct B-cell disorder resulting from the accumulation, predominantly in the bone marrow, of clonally related lymphoplasmacytic cells, which secrete a monoclonal IgM protein. The paramters predicting prognosis of WM are list below: Table 1 International Prognostic Scoring System for WM. Factor associated with WM prognosis Value Age, yr >65 […]

A Whole New Pharmacy Profession Forum


Hi, everyone. I just built a whole new website recent couple of days. It’s named “Pharmacy Profession Forum”. The forum welcome pharmacist, residents, students, and anyone who is interested in the profession of pharmacy all over the world. Join us today, Pharmacy Profession Forum (